Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986283 · ClinicalTrials.gov registry record · Phase 1
Abuse Potential Study of PF-00345439
A Phase 1 study, sponsored by Pain Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT01986283 is a Phase 1 study that has completed, run by Pain Therapeutics. The registered enrollment target is 67 participants.
The verdict
NCT01986283, a Phase 1 study, has completed, sponsored by Pain Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
This study will determine the relative abuse potential of intact and chewed PF-00345439 (Oxycodone Extended-Release Capsules) compared to crushed oxycodone HCL immediate release (IR) tablets and placebo administered orally to non-dependent, recreational opioid users.
Interventions
- DRUG oxycodone
- DRUG Capsule
- DRUG PF-00345439
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01986283
The ClinicalTrials.gov registry entry for NCT01986283 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pain Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which oxycodone is the first listed.
NCT01986283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01986283 about?
NCT01986283 is a clinical study titled "Abuse Potential Study of PF-00345439". This study will determine the relative abuse potential of intact and chewed PF-00345439 (Oxycodone Extended-Release Capsules) compared to crushed oxycodone HCL immediate release (IR) tablets and placebo administered orally to non-dependent, recreational opioid users.
What is the current status of trial NCT01986283?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2013-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01986283?
The interventions under investigation include: oxycodone (DRUG), Capsule (DRUG), PF-00345439 (DRUG).
Who is sponsoring clinical trial NCT01986283?
This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.